ClinicalTrials.Veeva

Menu

Bread Study: Comparison of the Tolerance of Spelt and Wheat Bread

U

University of Hohenheim

Status

Completed

Conditions

Non-celiac Gluten Sensitivity
Wheat Intolerance

Treatments

Other: bread

Study type

Interventional

Funder types

Other

Identifiers

NCT04401956
ErnMed-Brot

Details and patient eligibility

About

This project aims to verify the hypothesis that spelt products are more tolerable than bread wheat products in a target group of individuals with self-diagnosed wheat sensitivity. In addition, the influence of different manufacturing processes will be considered.

Full description

Wheat cereals are known to be capable of triggering wheat allergy and celiac disease. The prevalence of both diseases is about 1%. Recently, another clinical entity was described, the non-celiac wheat sensitivity (NCWS). The origin and mechanisms of NCWS are unclear at present, but the existence of this new disease entity has been proven by double-blind placebo-controlled challenge tests. Three different grain components have been proposed as triggers of NCWS, gluten, α-amylase trypsin inhibitors or fermentable carbohydrates (FODMAPs).

It is reported that individuals with self-diagnosed NCWS quite often tolerate spelt products much better, even though spelt shows a higher gluten content than bread wheat products. Therefore, the question arises whether this putative spelt tolerance can be confirmed on an objective basis and whether the underlying molecular mechanisms can be elucidated. So far, human study addressing such questions are lacking.

This project aims to verify the hypothesis that spelt products are more tolerable than bread wheat products in a target group of individuals with self-diagnosed wheat sensitivity. In addition, the influence of different manufacturing processes on wheat sensitivity will be revealed.

For this purpose, the trial involves individuals with self-diagnosed wheat sensitivity and spelt tolerance. Six different kinds of bread will be tested, including 4 wheat and spelt breads, each of them produced following a traditional or a conventional way. Aim of this part is to objective bread wheat and spelt intolerance in a defined population. To find out whether FODMAPs or gluten affect the tolerance of bread, two additional breads will be tested, a gluten-free bread with added gluten and a gluten-free bread with added FODMAPs.

Enrollment

24 patients

Sex

All

Ages

18 to 70 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Age ≥18 ≤70 years
  • Signed declaration of consent
  • Willingness to adhere to the prescribed diet for the duration of the study
  • Subjective bread wheat intolerance
  • No known spelled intolerance
  • No acute or chronic gastrointestinal diseases (e.g. celiac disease / wheat allergy)
  • No participation in another clinical trial (current or within the past 30 days)
  • Gluten-containing diet at least 6 weeks before the start of the study

Exclusion criteria

  • Taking intestinal therapeutics, antibiotics, immunosuppressants or similar
  • Pregnancy / lactation
  • Relevant violations of the nutritional protocol
  • Occurrence of relevant diseases (possibly individual decision)
  • Revocation of consent
  • Accommodation in a clinic or similar facility based on an official or judicial order

Trial design

Primary purpose

Supportive Care

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

Single Blind

24 participants in 6 patient groups

Gluten free bread with added gluten
Active Comparator group
Description:
Bread will be eaten by the participants for 4 consecutive days.
Treatment:
Other: bread
Gluten free bread with added FODMAPs
Active Comparator group
Description:
Bread will be eaten by the participants for 4 consecutive days.
Treatment:
Other: bread
Traditional manufactured wheat bread
Experimental group
Description:
Bread will be eaten by the participants for 4 consecutive days.
Treatment:
Other: bread
Traditional manufactured spelt bread
Experimental group
Description:
Bread will be eaten by the participants for 4 consecutive days.
Treatment:
Other: bread
Conventional manufactured wheat bread
Experimental group
Description:
Bread will be eaten by the participants for 4 consecutive days.
Treatment:
Other: bread
Conventional manufactured spelt bread
Experimental group
Description:
Bread will be eaten by the participants for 4 consecutive days.
Treatment:
Other: bread

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems